Mene ne IPF da kuma Me Yake Sa shi?
Idan kai ko wanda kake ƙaunata an gano shi tare da fibrosis na ƙwayoyin cuta na idiopathic (IPF), san cewa mutane da yawa sun san wannan cuta. Idan za ku fara nemo tsofaffin bayanai game da IPF, ba za ku iya samun labarai masu kyau ba. Har zuwa shekarar 2014, babu wata magungunan da aka samu wanda ya haifar da gagarumin bambanci ga mutanen da ke zaune tare da cutar. A gaskiya, wannan yana canza-yanzu akwai IS magani don cutar da ke inganta rayuwar.
Mene ne Fibrosis Pulmonary Falmonic (IPF)?
IPF shi ne mafi yawan al'ada na rukuni na cututtuka da aka sani da ƙwayar ƙwayar cuta na intstitial idiopathic. Kalmar interstitial tana nufin yanayin idan yanzu yana cikin yankunan huhu tsakanin alveoli ( ƙananan jakar iska a ƙarshen sashin jiki na numfashi a inda musayar oxygen da carbon dioxide ke faruwa) da kuma cikin haɗin ginin alveolar. Fibrosis na nufin mawuyacin hali. Yana da wannan nau'i a cikin ganuwar alveolar da kyallen takalma a tsakanin su wadanda suke rikitar da ikon oxygen don su shiga cikin ganuwar alveoli da cikin jini.
A baya, an yi tunanin cewa IPF wani tsari ne na ƙetarewa. Yanzu ana tunanin cewa yana farawa tare da lalacewa daga huhu daga haɗuwa da tushe, sannan magungunan wariyar launin fata-fibrosis.
Don tunanin abin da yake kama da wannan, yi la'akari da yanke akan fata ɗin da yake warkewa tare da tsawa. A cikin mutane da yawa, cututtuka ya warke tare da mai launi mai kyau wanda ya juya fari tare da lokaci.
A wasu mutane, fata yana warkar da ƙwayar cuta, yana barin ƙwaƙwalwar keloid mai ƙanshi da rashin lafiya . Fibrosis a cikin IPF yana kama da wannan nau'i, amma ba a bayyane a waje na jiki ba.
Bugu da ƙari, kasancewar ci gaba mai tsanani a kan kansa, kashi 10 cikin 100 na mutanen da ke da IPF ana sa ran samun ciwon daji na huhu.
Yaya Yadda ake amfani da IPF?
Lissafi sun bambanta lokacin kallon abin da ke faruwa na fibrosis na ƙwayar cuta na ƙwayar cuta, amma yarjejeniyar ita ce yanayin da aka gano ba; mutane da yawa suna da IPF kuma an gano su tare da wani yanayin, ko kuma sun wuce kafin a gane asali.
Bisa ga wani bincike a Amurka, an gano cewa tasirin (yawan mutanen da aka gano a kowace shekara) na IPF shine 58.7 a kowace 100,000. A cikin wani bincike na 2011, an gano cewa yawancin mutanen da ke tare da cutar) na IPF sune 495.5 lokuta da 100,000 Medicare masu amfana. (Wani cututtukan da ba a iya gani ba ne a matsayin wanda a cikin mutane 50,000 basu da cuta, saboda haka, IPF ba abu ba ne, amma ba a yi ba.)
Binciken mutuwar lamarin na IPF ya nuna cewa mutane 13,000 zuwa 17,000 zasu mutu daga IPF a Amurka a shekarar 2014 kuma tsakanin mutane 28,000 da 65,000 zasu mutu a Turai. Don sanya wannan a hangen zaman gaba, kimanin mutane 40,000 ne suka mutu daga ciwon nono a kowace shekara a Amurka, yin IPF babbar mawuyacin rashin lafiya da mutuwa.
Wane ne ke samun IPF? Dalili da Dalili Dama
Ba a san abin da ke haifar da IPF ba, sabili da haka, kalmar "idiopathic," wanda ke nufin "ba mu san dalilin ba." Wannan ya ce, akwai wasu matsalolin da zasu iya haifar da mutane zuwa cutar.
Wasu daga cikinsu sun haɗa da:
- Shekaru - IPF yawanci ana bincikar asibiti a cikin tsofaffi da kuma tsofaffi.
- Shan taba - Kusan kashi 60 cikin dari na mutanen da suka bunkasa IPF suna da tarihi na shan taba.
- Cutar cututtuka irin na cutar Epstein-Barr , wanda ke haifar da mononucleosis.
- Bayanin muhalli da kuma sana'a.
- Cutar Gidawar Gastroesophageal (GERD) - Mafi yawan mutanen da aka gano tare da IPF suna da tarihin GERD tare da ƙwannafi.
- Tarihin iyali ( jigilar kwayoyin halitta ) - IPF yana gudana a cikin iyalai da wasu maye gurbin jigilar jini ya bayyana ya ƙara haɗarin.
Akwai sanannun sanannun abubuwan da ke tattare da fibrosis na huhu, irin su radiation da magunguna, amma waɗannan ma'anar ba za a rarraba a ƙarƙashin fibrosis ba.
Kalma Daga
Don dalilan da ba a sani ba, masu mutuwa daga IPF sun kasance suna karuwa a dukan duniya. A lokaci guda kuma, an inganta sababbin jiyya yayin da bincike kan wannan cuta ta ci gaba . Bayan ganewar asali , kuma likitanka ya kamata ya yi aiki tare don samun wani zaɓi na yin aiki wanda ke aiki don shari'arka. Akwai magunguna daban-daban, kuma wasu marasa lafiya zasu iya zama 'yan takara don suturar daji. Bugu da ƙari, ƙungiyoyi masu goyan baya suna samuwa inda za ku iya haɗi tare da wasu kuma ku koyi dabaru don rayuwa mafi kyau duk da samun IPF. Daga qarshe, rawar da kake takawa a lafiyarka na iya yin bambanci, ma.
> Sources:
Antoniou, K., Tomassetti, S., Tsitoura, E., da kuma C. Vancheri. Idiopathic na huhu da fibrosis da ciwon huhu: kwakwalwa da pathogenesis sabuntawa. Rahotanni na yanzu a Magungunan Pulmonary . 2015 Satumba 18. (Epub gaba na buga).
Ghebremariam, Y. et al. Sakamakon sakamako na proton pump inhibitor esomeprazole abu don kawar da huhu ƙonewa da fibrosis. Journal of Translational Medicine . 2015. 13: 249.
Hutchinson, J., McKeever, T., Fogarty, A., Navaratnam, V., da kuma R. Hubbard. Ƙara yawan mace-mace na duniya daga cutar fibrois na ƙwayoyin cuta na marasa lafiya a cikin karni na ashirin da daya. Annals na Amurka Thoracic Society . 2014. 11 (8): 1176-85.
Cibiyar Nazarin Harkokin Harkokin Bincike na Cibiyar Nazarin Fibrosis, Martinez, F., DeAndrade, J., Anstrom, K., King, T., da G. Raghu. Rikicin gwajin acetylcysteine a cikin ƙwayar cuta na fibrosis. New England Journal of Medicine . 2014. 370 (22): 2093-101.
Spagnolo, P., Maher, T., da L. Richeldi. Idiopathic na huhu fibrosis: Ci gaba na gaba kan farfadowa da kwayar cutar. Pharmacology & Therapeutics . 2015. 152: 18-27.